Optimizing stroke prevention in atrial fibrillation: better adherence and compliance from patients and physicians leads to better outcomes

Tatjana S Potpara; Deirdre A Lane; Gregory Y H Lip

doi:10.1093/europace/euv041

Optimizing stroke prevention in atrial fibrillation: better adherence and compliance from patients and physicians leads to better outcomes

Tatjana S Potpara, Deirdre A Lane, Gregory Y H Lip

Research output: Contribution to journal › Editorial › peer-review

14 Citations (Scopus)

Original language	English
Pages (from-to)	507-508
Number of pages	2
Journal	EP Europace
Volume	17
Issue number	4
Early online date	30 Mar 2015
DOIs	https://doi.org/10.1093/europace/euv041
Publication status	Published - Apr 2015

Keywords

Anticoagulants
Atrial Fibrillation
Drug Administration Schedule
Female
Humans
Male
Medication Adherence
Registries
Rivaroxaban
Stroke
Thromboembolism
Withholding Treatment

Access to Document

10.1093/europace/euv041Licence: None: All rights reserved

https://doi.org/10.1093/europace/euv041Licence: None: All rights reserved

Cite this

@article{82f8e27930ac4ff6bb1fce437df45183,

title = "Optimizing stroke prevention in atrial fibrillation: better adherence and compliance from patients and physicians leads to better outcomes",

keywords = "Anticoagulants, Atrial Fibrillation, Drug Administration Schedule, Female, Humans, Male, Medication Adherence, Registries, Rivaroxaban, Stroke, Thromboembolism, Withholding Treatment",

author = "Potpara, {Tatjana S} and Lane, {Deirdre A} and Lip, {Gregory Y H}",

year = "2015",

month = apr,

doi = "10.1093/europace/euv041",

language = "English",

volume = "17",

pages = "507--508",

journal = "EP Europace",

issn = "1099-5129",

publisher = "Oxford University Press",

number = "4",

}

TY - JOUR

T1 - Optimizing stroke prevention in atrial fibrillation

T2 - better adherence and compliance from patients and physicians leads to better outcomes

AU - Potpara, Tatjana S

AU - Lane, Deirdre A

AU - Lip, Gregory Y H

PY - 2015/4

Y1 - 2015/4

KW - Anticoagulants

KW - Atrial Fibrillation

KW - Drug Administration Schedule

KW - Female

KW - Humans

KW - Male

KW - Medication Adherence

KW - Registries

KW - Rivaroxaban

KW - Stroke

KW - Thromboembolism

KW - Withholding Treatment

U2 - 10.1093/europace/euv041

DO - 10.1093/europace/euv041

M3 - Editorial

C2 - 25833879

SN - 1099-5129

VL - 17

SP - 507

EP - 508

JO - EP Europace

JF - EP Europace

IS - 4

ER -